verdinexor (Laverdia-CA1)
Jump to navigation
Jump to search
Indications
- oral treatment for dogs with lymphoma
Dosage
- tabs: 2.5 mg, 10 mg, 50 mg
Mechanism of action
- inhibits nuclear export
More general terms
References
- ↑ FDA News Release. Jan 11, 2021 FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs. https://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-first-oral-tablet-treat-lymphoma-dogs
- ↑ Perwitasari O, Johnson S, Yan X et al Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo. J Virol. 2014 Sep 1;88(17):10228-43. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24965445 Free PMC article.